Isarna Therapeutics GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Isarna Therapeutics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013917
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Isarna Therapeutics GmbH (Isarna), formerly Antisense Pharma GmbH is a healthcare products provider that develops products for ophthalmic, fibrotic diseases and cancers. The company offers antisense technology based drugs that treats aggressive tumor diseases. Its product include TGF-ß, a inhibitor that inhibits cancer cells and treats ophthalmic and fibrotic diseases. Isarna’s cytokine human transforming growth factor beta is used for cell proliferation, immune response, cell differentiation, and tissue modeling. The company also offers next generation antisense oligonucleotide candidates that targets TGF-ß isoforms for treating solid tumors. Isarna Therapeutics is headquartered in Munich, Germany.

Isarna Therapeutics GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Isarna Therapeutics Raises US$7.6 Million In Venture Financing 10
Isarna Therapeutics Raises US$18 Million In Venture Financing 11
Antisense Pharma Raises US$11.6 Million In Venture Financing 12
Licensing Agreements 13
Isarna Therapeutics Enters Into Licensing Agreement With Santaris Pharma To Develop Oligonucleotides For TGF-ß-Mediated Diseases 13
Asset Transactions 14
Autotelic Acquires Trabedersen from Isarna Therapeutics 14
Isarna Therapeutics GmbH – Key Competitors 15
Isarna Therapeutics GmbH – Key Employees 16
Isarna Therapeutics GmbH – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Clinical Trials 18
May 04, 2016: Isarna Presents First Interim Phase I Data for ISTH0036 in Advanced Glaucoma at ARVO 2016 Annual Conference 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Isarna Therapeutics GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Isarna Therapeutics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Isarna Therapeutics Raises US$7.6 Million In Venture Financing 10
Isarna Therapeutics Raises US$18 Million In Venture Financing 11
Antisense Pharma Raises US$11.6 Million In Venture Financing 12
Isarna Therapeutics Enters Into Licensing Agreement With Santaris Pharma To Develop Oligonucleotides For TGF-ß-Mediated Diseases 13
Autotelic Acquires Trabedersen from Isarna Therapeutics 14
Isarna Therapeutics GmbH, Key Competitors 15
Isarna Therapeutics GmbH, Key Employees 16
Isarna Therapeutics GmbH, Subsidiaries 17

★海外企業調査レポート[Isarna Therapeutics GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Press Association:企業の戦略・SWOT・財務情報
    Press Association - Strategy, SWOT and Corporate Finance Report Summary Press Association - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Levi Strauss & Co.:企業の戦略・SWOT・財務情報
    Levi Strauss & Co. - Strategy, SWOT and Corporate Finance Report Summary Levi Strauss & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mettler-Toledo International Inc:企業の戦略・SWOT・財務分析
    Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report Summary Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Physio-Control Inc-医療機器分野:企業M&A・提携分析
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Bain Capital LLC is a medical device company that offers development, manufacturing, sale and service of emergency medical response products. The company provides pre-hospital, hospital, military, and accessory and disposable products. Its …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Molecular Warehouse Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Molecular Warehouse Ltd (Molecular Warehouse) is a developer of proteins for diagnostic and therapeutic use. The company helps prevent diseases by empowering people with molecular diagnostics. Its synthetic biology techniques enabled it to reengineer glucose dehydrogenase, and enzymes found …
  • CapitaLand Limited:企業のM&A・事業提携・投資動向
    CapitaLand Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CapitaLand Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Bechtel Corporation:電力:M&Aディール及び事業提携情報
    Summary Bechtel Corporation (Bechtel) is a provider of engineering, construction and project management services. It provides a diverse portfolio of services to energy, transportation, infrastructure, communications, mining and metals, oil and gas, chemicals, water, defense and nuclear, and governme …
  • OAO Gazprom:企業の戦略・SWOT・財務情報
    OAO Gazprom - Strategy, SWOT and Corporate Finance Report Summary OAO Gazprom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Paramedical Srl:企業の製品パイプライン分析2018
    Summary Paramedical Srl (Paramedical) is a medical equipment company that manufactures clinical chemistry, turbidimetry and instruments for laboratories. The company’s products include in vitro diagnostics and equipment, automated immunoassay, brochure regents and instruments, centrifuges, chemistry …
  • Somany Ceramics Limited (SOMANYCERA):企業の財務・戦略的SWOT分析
    Somany Ceramics Limited (SOMANYCERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Japan Airlines Co Ltd:企業のM&A・事業提携・投資動向
    Japan Airlines Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Japan Airlines Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Zion Oil & Gas Inc (ZN):石油・ガス:M&Aディール及び事業提携情報
    Summary Zion Oil & Gas Inc (Zion Oil) is an oil and gas company that explores and produces oil and gas properties in Israel. The company offers services such as geophysical, geological, and other science-based studies and surveys to support oil and gas exploration and development services. It holds …
  • Energy Development Corp (EDC):電力:M&Aディール及び事業提携情報
    Summary Energy Development Corp (EDC), formerly Philippine National Oil Company, is a diversified renewable energy company. The company explores, develops, operates and utilizes geothermal energy and other indigenous renewable energy projects in the Philippines. EDC by utilizing geothermal energy an …
  • Zhejiang Hisun Pharmaceutical Co Ltd (600267):企業の財務・戦略的SWOT分析
    Summary Zhejiang Hisun Pharmaceutical Co Ltd (Hisun) manufactures and commercializes drugs to treat tumor, infections, cardiovascular, endocrine, depression and orthopaedic disorders. The company’s product portfolio includes anti-tumor and anti-viral, hypoglycemic drugs, animal health products, oral …
  • Osprey Medical Inc (OSP):医療機器:M&Aディール及び事業提携情報
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • SteadyMed Therapeutics Inc:製品パイプライン分析
    Summary SteadyMed Therapeutics Inc (SteadyMed), a subsidiary of SteadyMed Ltd is a pharmaceutical company that develops and commercializes therapeutic product candidates. The company provides patchpump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large …
  • PDC Energy Inc (PDCE):企業の財務・戦略的SWOT分析
    Summary PDC Energy Inc (PDC Energy) is an oil and gas company. It is engaged in production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal drilling and low-risk organic development of oil and natural gas reserves from shales …
  • Cabela’s Incorporated:企業の戦略・SWOT・財務情報
    Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report Summary Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Insightra Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company provides cardiovascular and surgical solutions. It offers cardiovascular solutions such as Ultra 7FR IAB and modulare. The Modula …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆